Buscar resultados de ensayos clínicos
Mucopolysaccharidosis I - 101 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Phase I/II Study of Retroviral-Mediated Transfer of Iduronate-2-Sulfatase Gene Into Lymphocytes of Patients With Mucopolysaccharidosis II (Mild Hunter Syndrome) Condición: Mucopolysaccharidosis II Fecha: 1999-10-18 Intervenciones: Genetic: lymphocyte gene therapy |
Recruiting |
Nombre del estudio: A Study of JR-141 in Patients With Mucopolysaccharidosis Type II Condición: Mucopolysaccharidosis II Fecha: 2017-04-10 Intervenciones: Drug: JR-141 IV infusion (lyophilized powder), 0.01-2.0 mg/kg/week |
Recruiting |
Nombre del estudio: The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients Condición: Hunter Syndrome Fecha: 2014-01-19 |
Completed |
Nombre del estudio: A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723 Condición: Mucopolysaccharidosis II Fecha: 2012-05-17 Intervenciones:
|
Completed |
Nombre del estudio: Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase Condición:
|
Recruiting |
Nombre del estudio: Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age Condición: Hunter Syndrome Fecha: 2015-05-20 Intervenciones: Drug: Elaprase for intravenous (IV) infusion Patients enrolled in this study will receive once-weekly IV |
Completed |
Nombre del estudio: Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome Condición: Hunter Syndrome Fecha: 2011-10-06 Intervenciones: Other: No treatment |
Completed |
Nombre del estudio: Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy Condición:
|
Completed |
Nombre del estudio: An Observational Study Evaluating Anti-Idursulfase Serum Antibody Response in Hunter Syndrome Patients Condición: Hunter Syndrome Fecha: 2009-04-16 Intervenciones: Biological: Idursulfase Patients received idursulfase as prescribed by their physician following locally |
Completed |
Nombre del estudio: A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® Condición: Hunter Syndrome Fecha: 2009-06-12 Intervenciones:
|